KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Accumulated Depreciation (2020 - 2021)

Twist Bioscience (TWST) has disclosed Accumulated Depreciation for 1 consecutive years, with $35.4 million as the latest value for Q3 2021.

  • On a quarterly basis, Accumulated Depreciation changed N/A to $35.4 million in Q3 2021 year-over-year; TTM through Sep 2021 was $35.4 million, a N/A change, with the full-year FY2021 number at $35.4 million, changed N/A from a year prior.
  • Accumulated Depreciation was $35.4 million for Q3 2021 at Twist Bioscience.
  • In the past five years, Accumulated Depreciation ranged from a high of $35.4 million in Q3 2021 to a low of $35.4 million in Q3 2021.